Bayer responds to CCI queries on Monsanto deal

German drugs and agrochemicals company Bayer said it had replied to queries raised by the Competition Commission of India (CCI) on the possible implications for this country's agricultural biotechnology sector from its proposed acquisition of Monsanto’s global operations.

Bayer will need approvals from regulators of at least 30 countries it operates in. Of these, it has got approval from 11 countries. And, regulators across 14 countries have set conditional precedents for approvals on the deal. 

In India, the integration process is subject to approvals from CCI; Bayer applied to it in early August. “Bayer has responded to various clarifications and explanations sought